Keyphrases
Long-term Exposure
100%
Testosterone Replacement Therapy
100%
High-grade Prostate Cancer
100%
Testosterone
80%
Medicare
40%
Non-associated
40%
Population-based Study
20%
Demographic Characteristics
20%
Prostate Cancer
20%
Dose-response
20%
Autopsy
20%
Cancer Diagnosis
20%
Tumor Staging
20%
Surveillance Epidemiology
20%
Logistic Regression
20%
Clinical Characteristics
20%
Tumor Grade
20%
Health Maintenance Organizations
20%
Androgen Deprivation Therapy
20%
Benefit-risk Assessment
20%
Cumulative Counts
20%
Testosterone Deficiency
20%
Medicine and Dentistry
Long Term Exposure
100%
Prostate Cancer
100%
Androgen Therapy
100%
Testosterone
66%
Diagnosis
50%
Man
50%
Medicare
33%
Injection
33%
Disease
16%
Therapeutic Procedure
16%
Patient
16%
Death
16%
Assessment
16%
Health
16%
Neoplasm
16%
Cancer Diagnosis
16%
Cancer Staging
16%
Surveillance, Epidemiology, and End Results
16%
Logistic Regression Analysis
16%
Dose Response
16%
Androgen Deprivation Therapy
16%
Androgen Deficiency
16%
INIS
cancer
100%
risks
100%
therapy
100%
prostate
100%
testosterone
100%
men
33%
tumors
22%
injection
22%
patients
11%
diseases
11%
populations
11%
data
11%
death
11%
doses
11%
information
11%
assessments
11%
epidemiology
11%
maintenance
11%
surveillance
11%
incidents
11%
androgens
11%
receipts
11%
autopsy
11%
Pharmacology, Toxicology and Pharmaceutical Science
Long Term Exposure
100%
Prostate Cancer
100%
Testosterone
100%
Diseases
12%
Malignant Neoplasm
12%
Neoplasm
12%
Death
12%
Epidemiology
12%
Androgen
12%
Cancer Staging
12%
Androgen Deficiency
12%